NCT01665703View on ClinicalTrials.gov

Imaging Correlates of Renal Cell Carcinoma Biological Features

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2019

Conditions
Renal Cell Carcinoma
Interventions
PROCEDURE

FDG PET/MR

Patients will be asked to undergo a voluntary gadolinium enhanced MRI with simultaneous acquisition of FDG-PET uptake within 4 weeks prior to surgery.

Trial Locations (1)

27599

Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01665703 - Imaging Correlates of Renal Cell Carcinoma Biological Features | Biotech Hunter | Biotech Hunter